LACOG - Latin American Cooperative Oncology Group· @LACOG_group · X·· 2 天前评分70
正文 · 原文
On October 23, LACOG investigator Dr. Carlos H. Barrios presented health-related quality-of-life results and patient-reported outcomes from DESTINY-Breast05 at ESMO Congress 2026 in Madrid.
#LACOG #ESMO2026
7 浏览 · 0 赞 · 0 转发 · 0 回复
会议摘要
539RO按 Rapid oral: Breast cancer, early stage 对上
Patient-reported outcomes (PROs) from DESTINY-Breast05: Health-related quality of life (HRQoL) with trastuzumab Deruxtecan (T-DXd) versus trastuzumab emtansine (T-DM1) in patients (Pts) with high-risk HER2-positive early breast cancer (eBC)
https://esmocongress.esmo.org来源：LACOG - Latin American Cooperative Oncology Group · x.com